Cargando…

Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses

Detalles Bibliográficos
Autores principales: Heery, Christopher R, Donahue, Renee, Lepone, Lauren, Grenga, Italia, Richards, Jacob, Metenou, Simon, Fernando, Romaine I, Dirmeier, Ulrike, Singh, Harpreet, Madan, Ravi, Gulley, James L, Schlom, Jeffrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645490/
http://dx.doi.org/10.1186/2051-1426-3-S2-P132
_version_ 1782400824344838144
author Heery, Christopher R
Donahue, Renee
Lepone, Lauren
Grenga, Italia
Richards, Jacob
Metenou, Simon
Fernando, Romaine I
Dirmeier, Ulrike
Singh, Harpreet
Madan, Ravi
Gulley, James L
Schlom, Jeffrey
author_facet Heery, Christopher R
Donahue, Renee
Lepone, Lauren
Grenga, Italia
Richards, Jacob
Metenou, Simon
Fernando, Romaine I
Dirmeier, Ulrike
Singh, Harpreet
Madan, Ravi
Gulley, James L
Schlom, Jeffrey
author_sort Heery, Christopher R
collection PubMed
description
format Online
Article
Text
id pubmed-4645490
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46454902015-11-20 Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses Heery, Christopher R Donahue, Renee Lepone, Lauren Grenga, Italia Richards, Jacob Metenou, Simon Fernando, Romaine I Dirmeier, Ulrike Singh, Harpreet Madan, Ravi Gulley, James L Schlom, Jeffrey J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645490/ http://dx.doi.org/10.1186/2051-1426-3-S2-P132 Text en Copyright © 2015 Heery et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Heery, Christopher R
Donahue, Renee
Lepone, Lauren
Grenga, Italia
Richards, Jacob
Metenou, Simon
Fernando, Romaine I
Dirmeier, Ulrike
Singh, Harpreet
Madan, Ravi
Gulley, James L
Schlom, Jeffrey
Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses
title Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses
title_full Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses
title_fullStr Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses
title_full_unstemmed Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses
title_short Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses
title_sort phase i, dose-escalation, clinical trial of mva-brachyury-tricom vaccine demonstrating safety and brachyury-specific t cell responses
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645490/
http://dx.doi.org/10.1186/2051-1426-3-S2-P132
work_keys_str_mv AT heerychristopherr phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses
AT donahuerenee phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses
AT leponelauren phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses
AT grengaitalia phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses
AT richardsjacob phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses
AT metenousimon phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses
AT fernandoromainei phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses
AT dirmeierulrike phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses
AT singhharpreet phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses
AT madanravi phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses
AT gulleyjamesl phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses
AT schlomjeffrey phaseidoseescalationclinicaltrialofmvabrachyurytricomvaccinedemonstratingsafetyandbrachyuryspecifictcellresponses